Z-1619-2020 Class II Terminated
FDA device recall Z-1619-2020 was initiated by The Binding Site Group, Ltd. on Apr 25, 2019 and is designated Class II. Reason for recall: A reagent in C reactive protein kits is not performing to specification and samples with known concentrations less-than-or-equal to 10 mg/L may be affected The recall status is terminated (terminated Apr 27, 2021). Affected quantity: 1 kit.
Recall details
- Product Type
- Devices
- Report Date
- Apr 8, 2020
- Initiation Date
- Apr 25, 2019
- Termination Date
- Apr 27, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1 kit
Product description
C-Reactive Protein Kit for use on the SPAplus, REF NK044.S.A, Rx only, UDI (01)05051700018456,
Reason for recall
A reagent in C reactive protein kits is not performing to specification and samples with known concentrations less-than-or-equal to 10 mg/L may be affected
Distribution pattern
U.S.: FL
Code information
Lot 455672
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1619-2020
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for The Binding Site Group, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.